Published on: April 4, 2012
by The Mirror
Cholesterol-busting statins may help to ward off Alzheimer’s disease if prescribed early, say experts.
Earlier work showed simvastatin improves blood flow in the brains of year-old lab mice with Alzheimer’s. A new study found it also boosts learning and memory, but only in six-month-old mice when the dementia disorder has not progressed.
The drug had no effect on an Alzheimer’s hallmark – the build up of amyloid beta protein in the brain. Simvastatin can be bought over the counter but its effect on human Alzheimer’s is still unclear, Canada’s McGill University said.
Study leader Dr Edith Hamel added in the Journal of Neuroscience: “This study shows that simvastatin can protect against some of the damaging effects of Alzheimer’s disease on nerve cells involved in memory, if administered early in the disease process.”
Dr Simon Ridley, from the charity Alzheimer’s Research UK, said: “Overall evidence suggests that statins like simvastatin do not benefit people with dementia, but this new mouse study suggests that the timing of treatment could be vital.
“Many experts believe that treatments for dementia will be most beneficial if given very early in the disease process.
“While these new findings are valuable, the benefits are shown in mice and we don’t know how they will bear out in humans.
“There is a real need to push on with research that will boost early detection and help people with dementia get more benefit from treatments.”
US Alzheimer’s expert Dr Ling Li, from the University of Minnesota, said: “This article joins an increasing number of pre-clinical studies demonstrating that statins, in particular simvastatin – which easily penetrates the brain – can counteract some aspects of Alzheimer’s disease, despite seeing no effects on amyloid-beta protein.
“Although several clinical trials have yet to show the benefits of statins for Alzheimer’s disease, the key now is to figure out how to translate these exciting findings from bench to bedside.”
In a new study, University of Nebraska–Lincoln sociologist Marc A. Garcia explored how educational attainment can benefit cognitive health in later life, and whether there are differences in its benefits among minorities. Garcia and his co-authors...
A genetic variation in some people may be associated with cognitive decline that can’t be explained by deposits of two key proteins associated with Alzheimer’s disease, amyloid β and tau, according to a study...
As 2020 drags on and the Covid-19 pandemic continues to ravage the world, the number of people reporting mental health issues, including anxiety, depression and stress, has skyrocketed. According to recent data, symptoms of anxiety and...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.